HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Kubo Selected Research

Indicators and Reagents (Reagents)

6/2001Antibodies to Th/To ribonucleoprotein in patients with localized scleroderma.
1/2000Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Kubo Research Topics

Disease

11Systemic Scleroderma (Systemic Sclerosis)
03/2006 - 01/2000
6Inflammation (Inflammations)
03/2013 - 02/2001
5Dermatomyositis (Dermatopolymyositis)
11/2017 - 06/2000
5Brain Injuries (Brain Injury)
01/2010 - 01/2006
5Localized Scleroderma (Morphea)
07/2006 - 01/2000
4Interstitial Lung Diseases (Interstitial Lung Disease)
01/2018 - 06/2000
4Type 2 Diabetes Mellitus (MODY)
06/2017 - 09/2001
4Colitis
03/2013 - 02/2001
4Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2006 - 01/2000
3Hypersensitivity (Allergy)
02/2014 - 03/2001
3Stomach Neoplasms (Stomach Cancer)
02/2010 - 05/2004
3Cicatrix (Scar)
10/2009 - 11/2000
3Insulin Resistance
05/2008 - 03/2001
3Fibrosis (Cirrhosis)
05/2006 - 01/2000
3Atrophy
09/2003 - 06/2000
3Neoplasms (Cancer)
10/2001 - 01/2000
2Major Depressive Disorder (Major Depressive Disorders)
12/2016 - 10/2013
2Breast Neoplasms (Breast Cancer)
08/2014 - 10/2001
2Ulcerative Colitis
03/2013 - 02/2001
2Infections
02/2011 - 11/2003
2Hyperthermia
01/2010 - 01/2008
2Brain Neoplasms (Brain Tumor)
01/2010 - 01/2008
2Sclerosis
05/2006 - 01/2000
2Cushing Syndrome
12/2001 - 06/2001
2Myositis (Idiopathic Inflammatory Myopathies)
11/2001 - 11/2000
1Bronchiectasis
01/2018
1Disease Susceptibility (Diathesis)
01/2018
1Vascular Diseases (Vascular Disease)
01/2018
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2017
1Melanoma (Melanoma, Malignant)
11/2017
1Tuberculosis (Tuberculoses)
01/2017
1Neuroblastoma
12/2016
1Dental Caries (Decay, Dental)
12/2016
1Disease Progression
11/2016
1Asthma (Bronchial Asthma)
04/2016
1Peripheral Nervous System Diseases (PNS Diseases)
08/2014
1Body Weight (Weight, Body)
03/2013
1Allergic Rhinitis
01/2013
1Parkinson Disease (Parkinson's Disease)
08/2012
1Calcinosis
10/2009
1Telangiectasis (Telangiectasia)
10/2009
1Ischemic Stroke
05/2008
1Pituitary ACTH Hypersecretion
01/2008
1Contrecoup Injury
01/2007
1Human Influenza (Influenza)
07/2006

Drug/Important Bio-Agent (IBA)

6AntibodiesIBA
11/2001 - 01/2000
5Proteins (Proteins, Gene)FDA Link
05/2008 - 11/2000
4RNA (Ribonucleic Acid)IBA
05/2002 - 09/2000
3CollagenIBA
01/2018 - 12/2001
3Metformin (Glucophage)FDA LinkGeneric
06/2017 - 09/2014
3Dextran SulfateIBA
03/2013 - 02/2001
3AgarIBA
01/2010 - 01/2007
3Carbon MonoxideIBA
10/2009 - 06/2000
3Adrenocorticotropic Hormone (ACTH)FDA Link
01/2008 - 06/2001
3ElementsIBA
01/2008 - 01/2006
3Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
05/2006 - 03/2001
3Glucose (Dextrose)FDA LinkGeneric
08/2005 - 06/2004
3ImmunosorbentsIBA
06/2002 - 01/2000
3EnzymesIBA
06/2002 - 01/2000
3Biomarkers (Surrogate Marker)IBA
06/2001 - 04/2000
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
12/2016 - 10/2013
2Serotonin (5 Hydroxytryptamine)IBA
12/2016 - 07/2002
2ArginaseIBA
02/2014 - 03/2013
2Arginine (L-Arginine)FDA Link
02/2014 - 03/2013
2Shape Memory AlloysIBA
01/2010 - 01/2008
2Insulin (Novolin)FDA Link
05/2008 - 03/2001
2Matrix Metalloproteinase 13IBA
07/2006 - 03/2006
2Transforming Growth Factor beta (TGF-beta)IBA
05/2006 - 02/2006
2Hydrocortisone (Cortisol)FDA LinkGeneric
04/2006 - 12/2001
2Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
11/2002 - 06/2001
2Anti-Bacterial Agents (Antibiotics)IBA
11/2001 - 03/2000
2RibonucleoproteinsIBA
09/2001 - 06/2001
2Hypoglycemic Agents (Hypoglycemics)IBA
09/2001 - 03/2001
2Indicators and Reagents (Reagents)IBA
06/2001 - 01/2000
2Apolipoproteins E (ApoE)IBA
05/2001 - 10/2000
2AutoantibodiesIBA
11/2000 - 01/2000
2Prion ProteinsIBA
10/2000 - 02/2000
2E-SelectinIBA
08/2000 - 01/2000
2SelectinsIBA
08/2000 - 01/2000
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
08/2000 - 01/2000
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2018
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2017
1HLA-DRB1 Chains (HLA DRB1)IBA
01/2017
1Virulence Factors (Pathogenicity Factors)IBA
01/2017
1LeukotrienesIBA
04/2016
1Paclitaxel (Taxol)FDA LinkGeneric
08/2014
1Immunoglobulin E (IgE)IBA
02/2014
13-nitrotyrosineIBA
02/2014
1NitratesIBA
03/2013
1Nitric Oxide Synthase (NO Synthase)IBA
03/2013
1Drinking WaterIBA
03/2013
1NitritesIBA
03/2013
1AllergensIBA
01/2013
1Zonisamide (Zonegran)FDA LinkGeneric
08/2012
1ProgesteroneFDA LinkGeneric
02/2011
1Estrogen Receptor alphaIBA
02/2010
1LigandsIBA
02/2010
1Fluorescent Dyes (Fluorescent Probes)IBA
05/2008

Therapy/Procedure

6Therapeutics
12/2016 - 06/2000
1Traction
01/2018